Micolucci Luigina, Akhtar Most Mauluda, Olivieri Fabiola, Rippo Maria Rita, Procopio Antonio Domenico
Computational Pathology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Laboratory of Experimental Pathology, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Oncotarget. 2016 Sep 6;7(36):58606-58637. doi: 10.18632/oncotarget.9686.
Asbestos is a harmful and exceptionally persistent natural material. Malignant mesothelioma (MM), an asbestos-related disease, is an insidious, lethal cancer that is poorly responsive to current treatments. Minimally invasive, specific, and sensitive biomarkers providing early and effective diagnosis in high-risk patients are urgently needed. MicroRNAs (miRNAs, miRs) are endogenous, non-coding, small RNAs with established diagnostic value in cancer and pollution exposure. A systematic review and a qualitative meta-analysis were conducted to identify high-confidence miRNAs that can serve as biomarkers of asbestos exposure and MM.
The major biomedical databases were systematically searched for miRNA expression signatures related to asbestos exposure and MM. The qualitative meta-analysis applied a novel vote-counting method that takes into account multiple parameters. The most significant miRNAs thus identified were then subjected to functional and bioinformatic analysis to assess their biomarker potential.
A pool of deregulated circulating and tissue miRNAs with biomarker potential for MM was identified and designated as "mesomiRs" (MM-associated miRNAs). Comparison of data from asbestos-exposed and MM subjects found that the most promising candidates for a multimarker signature were circulating miR-126-3p, miR-103a-3p, and miR-625-3p in combination with mesothelin. The most consistently described tissue miRNAs, miR-16-5p, miR-126-3p, miR-143-3p, miR-145-5p, miR-192-5p, miR-193a-3p, miR-200b-3p, miR-203a-3p, and miR-652-3p, were also found to provide a diagnostic signature and should be further investigated as possible therapeutic targets.
The qualitative meta-analysis and functional investigation confirmed the early diagnostic value of two miRNA signatures for MM. Large-scale, standardized validation studies are needed to assess their clinical relevance, so as to move from the workbench to the clinic.
石棉是一种有害且极其持久的天然物质。恶性间皮瘤(MM)是一种与石棉相关的疾病,是一种隐匿性、致命性癌症,对当前治疗反应不佳。迫切需要在高危患者中提供早期有效诊断的微创、特异性和敏感生物标志物。微小RNA(miRNA,miRs)是内源性非编码小RNA,在癌症和污染暴露方面具有既定的诊断价值。本研究进行了系统评价和定性荟萃分析,以鉴定可作为石棉暴露和MM生物标志物的高可信度miRNA。
系统检索主要生物医学数据库中与石棉暴露和MM相关的miRNA表达特征。定性荟萃分析应用了一种考虑多个参数的新型计数法。然后对如此鉴定出的最显著miRNA进行功能和生物信息学分析,以评估其作为生物标志物的潜力。
鉴定出一组具有MM生物标志物潜力的失调循环和组织miRNA,并将其命名为“间皮miRs”(MM相关miRNA)。比较石棉暴露者和MM患者的数据发现,作为多标志物特征最有前景的候选物是循环miR-126-3p、miR-103a-3p和miR-625-3p与间皮素的组合。最常被描述的组织miRNA,即miR-16-5p、miR-126-3p、miR-143-3p、miR-145-5p、miR-192-5p、miR-193a-3p、miR-200b-3p、miR-203a-3p和miR-652-3p,也被发现可提供诊断特征,应作为可能的治疗靶点进一步研究。
定性荟萃分析和功能研究证实了两种miRNA特征对MM的早期诊断价值。需要进行大规模、标准化的验证研究以评估其临床相关性,从而从实验室走向临床。